Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial

Shares of Novo Nordisk reached a record high after the company released promising data for amycretin, a new weight loss pill.

Mar 7, 2024 - 12:30
 0  3
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial
Shares of Novo Nordisk reached a record high after the company released promising data for amycretin, a new weight loss pill.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow